Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 3.26 USD -6.72%
Market Cap: 138.4m USD
Have any thoughts about
Repare Therapeutics Inc?
Write Note

Repare Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repare Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
B
DRUG
TH
AUPH
COV
EDT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Expenses
-$167.4m
CAGR 3-Years
-46%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Operating Expenses
-CA$7.4m
CAGR 3-Years
-148%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Expenses
-$55.9m
CAGR 3-Years
6%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Expenses
-$217.2m
CAGR 3-Years
2%
CAGR 5-Years
-25%
CAGR 10-Years
-30%
Covalon Technologies Ltd
XTSX:COV
Operating Expenses
-CA$17.9m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
-18%
Spectral Medical Inc
TSX:EDT
Operating Expenses
-CA$14.9m
CAGR 3-Years
-16%
CAGR 5-Years
-19%
CAGR 10-Years
-1%

See Also

What is Repare Therapeutics Inc's Operating Expenses?
Operating Expenses
-167.4m USD

Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Operating Expenses amounts to -167.4m USD.

What is Repare Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-67%

Over the last year, the Operating Expenses growth was -10%. The average annual Operating Expenses growth rates for Repare Therapeutics Inc have been -46% over the past three years , -67% over the past five years .

Back to Top